Loading the map…
Research and experimental development on biotechnology · Oxford
Eptiva Therapeutics
Eptiva Therapeutics Ltd
Private limited company registered in Oxford, classed under “Research and experimental development on biotechnology”.
Headline figures
FY to Oct 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
1 finding from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Profit after tax | — | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current assets | ||||
| Creditors due within a year | ||||
| Net current assets | ||||
| Net assets | ||||
| Ratios | ||||
| Current ratioCurrent assets for every £1 owed within a year | ||||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||||
4 balance-sheet lines and 2 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-25
- AccountsMicro company accounts made up to 31 October 2025
- AccountsMicro company accounts made up to 31 October 2024
- AccountsMicro company accounts made up to 31 October 2023
- SharesSub-division of shares on 14 February 2024
- FilingMemorandum and Articles of Association
- FilingResolutions
- SharesStatement of capital following an allotment of shares on 14 February 2024 · GBP 95.71 (and 2 more like it since 26 October 2023)
- AccountsMicro company accounts made up to 31 October 2022
- AccountsMicro company accounts made up to 31 October 2021
- AddressRegistered office address changed from 171 Crescent Road Oxford OX4 2NX England to 132 Gidley Way Horspath Oxford OX33 1TD on 9 March 2022
- FilingCorrection of a Director's date of birth incorrectly stated on incorporation / mr mark john field
- IncorporationIncorporation
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Eptiva Therapeutics do?
Private limited company registered in Oxford, classed under “Research and experimental development on biotechnology”.
›How much turnover does Eptiva Therapeutics make?
Answered in the full report
›Is Eptiva Therapeutics profitable?
Eptiva Therapeutics's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Eptiva Therapeutics?
Answered in the full report
›Who runs and owns Eptiva Therapeutics?
Its directors are Mark John Field, Harald Friedrich Stock. Its owners are shown to subscribers.
›Where is Eptiva Therapeutics based?
Its registered office is 132 Gidley Way, Horspath, Oxford, OX33 1TD, in Oxford.
›When was Eptiva Therapeutics founded?
Eptiva Therapeutics Ltd was incorporated on 21 October 2020.
›Is Eptiva Therapeutics still trading?
The register lists Eptiva Therapeutics Ltd as active.